加拿大ProMetic Life Sciences Inc.  www.prometic.com
ProMetic Life Sciences Inc. 是一家專(zhuān)注于研發(fā)、制造與營(yíng)銷(xiāo)多種源自其專(zhuān)有 Mimetic Ligand(TM) 技術(shù)的商業(yè)性應(yīng)用產(chǎn)品的生物制藥公司。Mimetic Ligand(TM) 技術(shù)被用于大規(guī)模的生物制劑凈化以及病原體消滅。ProMetic 還積極從事治療藥物的開(kāi)發(fā)，其使命是為市場(chǎng)提供有效、創(chuàng)新、成本更低、毒性更小的產(chǎn)品，用于治療血液疾病與癌癥。該公司的藥物發(fā)現(xiàn)平臺(tái)致力于用人工合成的“類(lèi)似藥物的”蛋白質(zhì)模擬產(chǎn)品來(lái)取代復(fù)雜昂貴的蛋白質(zhì)。ProMetic 總部位于加拿大蒙特利爾，在英國(guó)、美國(guó)和加拿大設(shè)有研發(fā)機(jī)構(gòu)，在英國(guó)設(shè)有制造工廠，并在美國(guó)、歐洲、亞洲以及中東開(kāi)展業(yè)務(wù)開(kāi)發(fā)活動(dòng)。

ProMetic is a global biopharmaceutical company offering technologies for large-scale drug purification, drug development, proteomics (the study of proteins), and the elimination of pathogens. ProMetic is also active in therapeutic drug development with the mission of bringing to market effective, innovative, lower cost products for the treatment of hematological and nephrological disorders and cancer. Headquartered in Montréal (Canada), ProMetic has R&D facilities in the UK, the USA and Canada, manufacturing facilities in the UK and business development activities in the USA, Europe, Asia and in the Middle-East. ProMetic focuses its activities in the Protein Technologies and Therapeutics markets.